USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
31-Jul-2025
Global
Technology Research
DB32-01-00-00-00
HC_2025_33697
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA).
It highlights key players in each segment and their role in advancing the RNA therapeutics landscape.
The research also provides insight into intellectual property trends, along with major partnerships, collaborations, acquisitions, and funding activities driving market growth.
This report answers the following questions:
1. What are the key drivers and restraints in the RNA therapeutics industry?
2. How fast is clinical development progressing across segments?
3. Which companies are leading innovation in RNA therapeutics?
4. What does the funding and partnership landscape look like?
5. Where are the growth opportunities in RNA therapeutics?
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8
The Impact of the Top 3 Strategic Imperatives on the RNA Therapeutics Industry
Growth Opportunities Fuel the Growth Pipeline Engine
Research Methodology
Scope of Analysis
Segmentation
Growth Drivers
Growth Restraints
The Emerging Landscape of RNA Therapeutics
Innovations in the Delivery Of RNA Therapeutics
Clinical Trial Analysis of mRNA Therapeutics
Key Innovators in mRNA-based Therapeutics
Clinical Trial Analysis of siRNA Therapeutics
Key Innovators in siRNA-based Therapeutics
Clinical Trial Analysis of ASO Therapeutics
Key Innovators in ASO-based Therapeutics
Clinical Trial Analysis of Other Emerging RNA Therapeutics
Key Innovators in Aptamers and miRNA-based Therapeutics
Key Innovators in saRNA-, RNAa-, and tRNA-based Therapeutics
Key Innovators in CirRNA Therapeutics
Cumulative Analysis of the RNA Therapeutics with siRNA-based Therapeutics Leading The Landscape
Patent Analysis
Evolving RNA Therapeutics Landscape Comprising Emerging RNA Types
Increasing Private Funding for RNA Therapeutics
Partnership Landscape in RNA Therapeutics
Acquisitions and Mergers in RNA Therapeutics
Growth Opportunity 1: Focus on RNA Therapeutic Delivery
Growth Opportunity 2: Focus Beyond siRNA Therapeutics
Growth Opportunity 3: Disease Indication Expansion
Technology Readiness Levels TRL: Explanation
Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.
The study assesses key technology shifts, including rapid molecular t...
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
07 Aug 2026 | Global | Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The su...
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This report answers the following questions:
1. What are the key drivers and restraints in the RNA therapeutics industry? 2. How fast is clinical development progressing across segments? 3. Which companies are leading innovation in RNA therapeutics? 4. What does the funding and partnership landscape look like? 5. Where are the growth opportunities in RNA therapeutics?
| Deliverable Type | Technology Research |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | RNA therapeutics market |
| Keyword 2 | RNA pharma market analysis |
| Keyword 3 | genetic therapeutics innovation |
| Podcast | No |
| Predecessor | None |
| WIP Number | DB32-01-00-00-00 |